Patents by Inventor Christopher Ian Belyea

Christopher Ian Belyea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics
    Publication number: 20110092448
    Abstract: The present invention provides a method of improving the oral delivery of a parent peptide, comprising the step of linking the parent peptide to an added peptide to form a conjugate which has greater oral bioavailability than the parent molecule alone, the added peptide comprising a balance of hydrophobic and hydrophilic residues as defined herein. Conjugates for use in the method are also provided, as are pharmaceutical compositions comprising the conjugate and methods of treatment using the conjugate or pharmaceutical composition.
    Type: Application
    Filed: August 2, 2006
    Publication date: April 21, 2011
    Applicant: METABOLIC PHARMACEUTICALS LIMITED
    Inventor: Christopher Ian Belyea
  • Product and method for control of obesity
    Patent number: 7098029
    Abstract: The invention relates to food and beverage products which are useful in control of obesity. The food or beverage comprises or is made by a transgenic plant or parts thereof comprising a nucleic acid molecule, the nucleic acid molecule encoding a C-terminal growth hormone fragment which has the ability to modulate lipid metabolism. The transgenic plant may be used in a production of a fermented food or beverage product, or may be a part of an edible plant, such as a fruit or vegetable, including but not limited to tomato, banana, and potato.
    Type: Grant
    Filed: November 6, 2000
    Date of Patent: August 29, 2006
    Assignee: Metabolic Pharmaceuticals Limited
    Inventors: Christopher Ian Belyea, Frank Man-Woon Ng, Paul Vaughan
  • Product and method for control of obesity
    Publication number: 20040014639
    Abstract: This invention relates to the prevention and treatment of obesity in mammals, especially humans. In particular, the invention relates to a method of treating obesity in a mammal, comprising the step of administering to the mammal a therapeutically-effective amount of an agent which increases the expression of beta-3 adrenergic receptors in the mammal, together with an agonist of the beta 3 adrenergic receptor.
    Type: Application
    Filed: August 14, 2003
    Publication date: January 22, 2004
    Inventors: Christopher Ian Belyea, Mark Heffernan, Roger Summers